Moriarty Thomas M
Moriarty Thomas M's purchase track record
Moriarty Thomas M has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/27/2026 | ACI | $1.96M | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
Transaction History
| ACI | ▲ Buy | Open Market | 170,500 | $2.0M | 7/27/2026 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 9,355 | — | 4/21/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 27,369 | $490K | 4/21/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 30,413 | $544K | 4/21/2026 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 13,078 | — | 4/21/2026 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 12,412 | — | 4/21/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 21,754 | $389K | 4/21/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 27,453 | $491K | 3/2/2026 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 11,805 | $211K | 3/2/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 29,488 | $528K | 3/2/2026 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 12,680 | $227K | 3/2/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 27,324 | $489K | 3/2/2026 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 12 | $210 | 3/2/2026 | View on chart |
| ACI | ▲ Buy | Option Exercise | 27,764 | $571K | 2/24/2025 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 12,647 | $260K | 2/24/2025 | View on chart |
| ACI | ▲ Buy | Option Exercise | 29,824 | $613K | 2/24/2025 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 13,585 | $279K | 2/24/2025 | View on chart |
| ACI | ▼ Sell | Tax Withholding | 12,704 | $272K | 2/26/2024 | View on chart |
| ACI | ▲ Buy | Option Exercise | 27,073 | — | 2/26/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 292,856 | $27.3M | 12/31/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 36,490 | $3.6M | 12/15/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 100,976 | $7.9M | 12/15/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 100,976 | $9.9M | 12/15/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 36,490 | $2.3M | 12/15/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 50,502 | $2.7M | 6/28/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 50,502 | $4.8M | 6/28/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 49,279 | $4.7M | 6/28/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 38,873 | $2.9M | 6/28/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 38,873 | $3.7M | 6/28/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 49,279 | $2.9M | 6/28/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,556 | $359K | 4/3/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 105,854 | $10.7M | 4/1/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 51,361 | $5.4M | 3/15/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 51,361 | $5.3M | 3/15/2022 | View on chart |
| CVS | ▲ Buy | Grant | 214,930 | $0 | 2/21/2022 | View on chart |
| CVS | ▲ Buy | Grant | 572,542 | $0 | 2/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ACI Faces Q2 Sales Pressure Amid Store Closures
Albertsons is expected to report second-quarter results below analyst consensus, with RBC noting a larger-than-expected decline in identical sales. The company continues to close stores at a recently acquired chain while facing price competition from Walmart. UBS highlights potential upside from its ACI Edge program despite near-term grocery challenges.
ACI Faces Q2 Sales Pressure Amid Store Closures. Albertsons is expected to report second-quarter results below analyst consensus, with RBC noting a larger-than-expected decline in identical sales. The company continues to close stores at a recently acquired chain while facing price competition from Walmart. UBS highlights potential upside from its ACI Edge program despite near-term grocery challenges.